Important pharmacy news and late-breaking industry information updated daily.

As part of its efforts to protect the nation's youth from the dangers of tobacco products and addiction, FDA announced Tuesday a crackdown on e-cigarettes, particularly the popular Juul devices.

A new DEA proposal aims to empower the agency to tighten overall quotas and individual quotas issued to drug manufacturers if it suspects supplies are being diverted for misuse. Capitol Hill aides and multiple former federal drug policy officials say the rule's effectiveness will depend on how often DEA chooses to enforce it.

This year marks the 10th anniversary of the presentation of awards

The Ohio Pharmacists Association (OPA) announced at its annual conference on Friday the creation of a task force to promote safe medication practices that prevent powerful opioids from getting into the wrong hands.

JAPhA study: Pharmacists may help improve appropriate use and disposal

An FDA advisory panel on Thursday unanimously recommended approval of a prescription cannabidiol medication for the treatment of rare forms of epilepsy.

Attorney General Jeff Sessions on Tuesday proposed new regulations that could severely limit the amount of opioids that drug companies can produce and force them to account for scores of illegitimate prescriptions across the country. The regulations would change how DEA sets production quotas for drug manufacturers.

Safety violations at a major compounding pharmacy are exacerbating hospital shortages of opioid analgesics, particularly in California where health officials have prohibited sales from one of its plants. In late March, California's Board of Pharmacy barred the distribution of medications from a Texas factory belonging to the company, PharMEDium.

Pharmacist-led comprehensive medication management may be the solution

FDA on Friday issued a new <a href="https://www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatory…; target="_blank">guidance</a> to clarify that dietary supplements containing pure or highly concentrated caffeine in powder or liquid forms are considered unlawful when sold in bulk quantities directly to consumers.